Cetera Investment Advisers Buys 463 Shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT)
Cetera Investment Advisers grew its stake in Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Free Report) by 4.3% in the 4th quarter, Holdings Channel.com reports. The fund owned 11,174 shares of the biotechnology company’s stock after purchasing an additional 463 shares during the quarter. Cetera Investment Advisers’ holdings in Sarepta Therapeutics were worth $1,359,000 as of its […]
